A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity

Journal of Personalized Medicine
Mara FornasarigRoberta Maestro

Abstract

Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the gastrointestinal tract, are characterized by activating mutations in KIT or PDGFRA genes. The vast majority of GISTs are sporadic, but rare hereditary forms have been reported, often featuring multifocality and younger age of onset. We here report the identification of a novel kindred affected by familial GIST caused by a KIT germline mutation in exon 13 (N655K). No family affected by hereditary GIST due to this KIT variant has been reported in literature so far. We were able to track the mutation in three members of the family (proband, mother, and second-degree cousin), all affected by multiple GISTs. Due to its rarity, the N655K variant is poorly characterized. We conducted in vitro drug sensitivity assays that indicated that most tyrosine kinase inhibitors (TKIs) currently included in the therapeutic armamentarium for GISTs have a limited inhibitory activity toward this mutation. However, when compared to a classical imatinib-resistant KIT mutation (T670I), N655K was slightly more sensitive to imatinib, and encouraging responses were observed with last-generation TKIs.

References

Nov 14, 2000·The American Journal of Pathology·K IsozakiJ M Vanderwinden
Dec 31, 2003·Gastroenterology·Agnès ChompretBrigitte Bressac-De Paillerets
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark E RobsonKenneth Offit
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuPeter Besmer
Mar 3, 2005·American Journal of Medical Genetics. Part a·Miguel CarballoMaría Martinez-Gimeno
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi TarnAndrew K Godwin
Sep 28, 2005·Pathology International·Hyun Jung KimJene Choi
Dec 6, 2005·The American Journal of Surgical Pathology·Ciarán O'RiainKieran Sheahan
Sep 27, 2006·The American Journal of Surgical Pathology·Jerzy Lasota, Markku Miettinen
Dec 30, 2006·Seminars in Diagnostic Pathology·Markku Miettinen, Jerzy Lasota
Jan 27, 2007·The American Journal of Surgical Pathology·Dae Young KangKyoung-Mee Kim
Sep 11, 2007·Archives of Pathology & Laboratory Medicine·Janet GrahamJeff D White
Oct 19, 2007·International Journal of Cancer. Journal International Du Cancer·Eric P KleinbaumJonathan C Trent
Jan 10, 2008·International Journal of Cancer. Journal International Du Cancer·Agnieszka WoźniakMaria Debiec-Rychter
Aug 2, 2008·The American Journal of Surgical Pathology·J Aidan Carney, Constantine A Stratakis
Aug 30, 2008·The American Journal of Surgical Pathology·Andreas ThalheimerEva Wardelmann
Mar 3, 2009·Hematology/oncology Clinics of North America·Rinki Agarwal, Mark Robson
Nov 16, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mayumi NakaiSeiichi Hirota
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard A SpeightSimon Panter
May 8, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jean-Baptiste BachetJean-François Emile
Jan 5, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Christopher L Corless
May 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick M FordeBen Ho Park
Sep 23, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew P GarnerVictor M Rivera
Dec 17, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Derek H JonesMarilyn M Bui
May 16, 2015·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Riccardo RicciLuigi M Larocca
Nov 27, 2015·The Journal of Pathology·Monica BrencaRoberta Maestro
Jun 20, 2016·Cancer Genetics·Riccardo RicciLuigi Maria Larocca
Jul 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniela GasparottoRoberta Maestro
Jul 21, 2016·Hereditary Cancer in Clinical Practice·Riccardo Ricci
Oct 25, 2016·Familial Cancer·Rita Vale RodriguesAntónio Dias Pereira
Feb 8, 2018·Trends in Cancer·Lin MeiSosipatros A Boikos

❮ Previous
Next ❯

Citations

Feb 3, 2021·Diagnostics·Iva BrčićBernadette Liegl-Atzwanger
Aug 7, 2021·Journal of Personalized Medicine·Leonhard Müllauer

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
SMA
genotyping

Software Mentioned

Miseq Reporter
VariantStudio

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

World Journal of Gastroenterology : WJG
Mehmet Ali Nahit SendurSercan Aksoy
International Journal of Cancer. Journal International Du Cancer
Agnieszka WozniakMaria Debiec-Rychter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Frederick P LiGeorge D Demetri
© 2021 Meta ULC. All rights reserved